Treatment of peripheral arterial disease using stem and progenitor cell therapy

Journal of Vascular Surgery

Volumn 53, Issue 2, 2011, Pages 445-453

  Lawall, Holger ^a   Bramlage, Peter ^b   Amann, Berthold ^c  

^a Klinikum Karlsbad Langensteinbach   (Germany)

^b Institute for Cardiovascular Pharmacology and Epidemiology   (Germany)

^c MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL ISOLATION; CELL TYPE; CLINICAL TRIAL; HUMAN; LIMB ISCHEMIA; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION; RISK ASSESSMENT; STEM CELL TRANSPLANTATION;

EID: 79251635436     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.08.060     Document Type: Review

References (56)

1. A.T. Hirsch, M.H. Criqui, D. Treat-Jacobson, J.G. Regensteiner, M.A. Creager, and J.W. Olin Peripheral arterial disease detection, awareness, and treatment in primary care JAMA 286 2001 1317 1324
2. J.W. Olin Thromboangiitis obliterans (Buerger's disease) N Engl J Med 343 2000 864 869
3. J. Ness, and W.S. Aronow Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice J Am Geriatr Soc 47 1999 1255 1256
4. H. Lawall, P. Bramlage, and B. Amann Stem cell and progenitor cell therapy in peripheral artery disease A critical appraisal Thromb Haemost 103 2010 696 709
5. D.J. Adam, J.D. Beard, T. Cleveland, J. Bell, A.W. Bradbury, and J.F. Forbes Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial Lancet 366 2005 1925 1934
6. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 e654
7. K. Hirota, and G.L. Semenza Regulation of angiogenesis by hypoxia-inducible factor 1 Crit Rev Oncol Hematol 59 2006 15 26
8. M. Voskuil, N. van Royen, I. Hoefer, I. Buschmann, W. Schaper, and J.J. Piek [Angiogenesis and arteriogenesis; the long road from concept to clinical application.] [Article in Dutch] Ned Tijdschr Geneeskd 145 2001 670 675
9. I. Buschmann, and W. Schaper The pathophysiology of the collateral circulation (arteriogenesis) J Pathol 190 2000 338 342
10. C. Heilmann, F. Beyersdorf, and G. Lutter Collateral growth: cells arrive at the construction site Cardiovasc Surg 10 2002 570 578
11. N. van Royen, J.J. Piek, I. Buschmann, I. Hoefer, M. Voskuil, and W. Schaper Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease Cardiovasc Res 49 2001 543 553
12. C. Diehm, H. Trampisch, R. Haberl, H. Darius, M. Mahn, and D. Pittrow Prognosis of patients with asymptomatic versus symptomatic peripheral arterial disease (PAD): 3-year results of the getABI study Vasc Med 12 2007 141 148
13. M. Heil, T. Ziegelhoeffer, B. Mees, and W. Schaper A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware Circ Res 94 2004 573 574
14. T. Kinnaird, E. Stabile, M.S. Burnett, and S.E. Epstein Bone-marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences Circ Res 95 2004 354 363
15. T. Kinnaird, E. Stabile, M.S. Burnett, C.W. Lee, S. Barr, and S. Fuchs Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms Circ Res 94 2004 678 685
16. D.K. Jin, K. Shido, H.G. Kopp, I. Petit, S.V. Shmelkov, and L.M. Young Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes Nat Med 12 2006 557 567
17. T. Asahara, T. Murohara, A. Sullivan, M. Silver, R. van der Zee, and T. Li Isolation of putative progenitor endothelial cells for angiogenesis Science 275 1997 964 967
18. J. Rehman, J. Li, C.M. Orschell, and K.L. March Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors Circulation 107 2003 1164 1169
19. T. Imanishi, T. Hano, T. Sawamura, and I. Nishio Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction Clin Exp Pharmacol Physiol 31 2004 407 413
20. T. Kondo, M. Hayashi, K. Takeshita, Y. Numaguchi, K. Kobayashi, and S. Iino Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers Arterioscler Thromb Vasc Biol 24 2004 1442 1447
21. C.J. Loomans, E.J. de Koning, F.J. Staal, M.B. Rookmaaker, C. Verseyden, and H.C. de Boer Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes Diabetes 53 2004 195 199
22. M. Vasa, S. Fichtlscherer, A. Aicher, K. Adler, C. Urbich, and H. Martin Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease Circ Res 89 2001 E1 E7
23. S. Zhu, X. Liu, Y. Li, P.J. Goldschmidt-Clermont, and C. Dong Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells Arterioscler Thromb Vasc Biol 27 2007 113 119
24. T. Asahara, H. Masuda, T. Takahashi, C. Kalka, C. Pastore, and M. Silver Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ Res 85 1999 221 228
25. T. Takahashi, C. Kalka, H. Masuda, D. Chen, M. Silver, and M. Kearney Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization Nat Med 5 1999 434 438
26. M.I. Niagara, H.Kh Haider, L. Ye, V.S. Koh, Y.T. Lim, and K.K. Poh Autologous skeletal myoblasts transduced with a new adenoviral bicistronic vector for treatment of hind limb ischemia J Vasc Surg 40 2004 774 785
27. Y. Takagi, T. Omura, M. Yoshiyama, R. Matsumoto, S. Enomoto, and T. Kusuyama Granulocyte-colony stimulating factor augments neovascularization induced by bone marrow transplantation in rat hindlimb ischemia J Pharmacol Sci 99 2005 45 51
28. H. Zhang, N. Zhang, M. Li, H. Feng, W. Jin, and H. Zhao Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb Ann Vasc Surg 22 2008 238 247
29. T. Ziegelhoeffer, B. Fernandez, S. Kostin, M. Heil, R. Voswinckel, and A. Helisch Bone marrow-derived cells do not incorporate into the adult growing vasculature Circ Res 94 2004 230 238
30. E. Tateishi-Yuyama, H. Matsubara, T. Murohara, U. Ikeda, S. Shintani, and H. Masaki Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial Lancet 360 2002 427 435
31. B.E. Strauer, M. Brehm, T. Zeus, M. Kstering, A. Hernandez, and R.V. Sorg Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 2002 1913 1918
32. G.P. Fadini, C. Agostini, and A. Avogaro Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature Atherosclerosis 209 2010 10 17
33. M.C. Caizo, F. Lozano, J.R. Gonzlez-Porras, M. Barros, N. Lpez-Holgado, and E. Briz Peripheral endothelial progenitor cells (CD133 +) for therapeutic vasculogenesis in a patient with critical limb ischemia One year follow-up Cytotherapy 9 2007 99 102
34. F.A. Kudo, T. Nishibe, M. Nishibe, and K. Yasuda Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia Int Angiol 22 2003 344 348
35. P.P. Huang, X.F. Yang, S.Z. Li, J.C. Wen, Y. Zhang, and Z.C. Han Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans Thromb Haemost 98 2007 1335 1342
36. N. van Royen, S.H. Schirmer, B. Atasever, C.Y. Behrens, D. Ubbink, and E.E. Buschmann START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease Circulation 112 2005 1040 1046
37. P. Romagnani, F. Annunziato, F. Liotta, E. Lazzeri, B. Mazzinghi, and F. Frosali CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors Circ Res 97 2005 314 322
38. M. Peichev, A.J. Naiyer, D. Pereira, Z. Zhu, W.J. Lane, and M. Williams Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors Blood 95 2000 952 958
39. G.P. Fadini, C. Agostini, S. Sartore, and A. Avogaro Endothelial progenitor cells in the natural history of atherosclerosis Atherosclerosis 194 2007 46 54
40. B. Amann, C. Luedemann, R. Ratei, and J.A. Schmidt-Lucke Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease Cell Transplant 18 2009 371 380
41. B. Amann, C. Ldemann, R. Rckert, H. Lawall, B. Liesenfeld, and M. Schneider Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI) Vasa 37 2008 319 325
42. A. Boyum Separation of lymphocytes, lymphocyte subgroups and monocytes: a review Lymphology 10 1977 71 76
43. A. Boyum Separation of lymphocytes, granulocytes, and monocytes from human blood using iodinated density gradient media Methods Enzymol 108 1984 88 102
44. A. Bøyum, D. Løvhaug, L. Tresland, and E.M. Nordlie Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality Scand J Immunol 34 1991 697 712
45. A. Bøyum, H. Brincker Fjerdingstad, I. Martinsen, T. Lea, and D. Løvhaug Separation of human lymphocytes from citrated blood by density gradient (NycoPrep) centrifugation: monocyte depletion depending upon activation of membrane potassium channels Scand J Immunol 56 2002 76 84
46. V. Prochzka, J. Gumulec, J. Chmelov, P. Klement, G.L. Klement, and T. Jonszta Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot Vnitr Lek 55 2009 173 178
47. M.H. Gastens, K. Goltry, W. Prohaska, D. Tschpe, B. Stratmann, and D. Lammers Good manufacturing practice-compliant expansion of marrow-derived stem and progenitor cells for cell therapy Cell Transplant 16 2007 685 696
48. K. Lenk, V. Adams, P. Lurz, S. Erbs, A. Linke, and S. Gielen Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia Eur Heart J 26 2005 1903 1909
49. V. Schchinger, B. Assmus, M.B. Britten, J. Honold, R. Lehmann, and C. Teupe Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial J Am Coll Cardiol 44 2004 1690 1699
50. V. Schchinger, S. Erbs, A. Elssser, W. Haberbosch, R. Hambrecht, and H. Hlschermann Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial Eur Heart J 27 2006 2775 2783
51. S. Janssens, C. Dubois, J. Bogaert, K. Theunissen, C. Deroose, and W. Desmet Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial Lancet 367 2006 113 121
52. F.H. Seeger, T. Tonn, N. Krzossok, A.M. Zeiher, and S. Dimmeler Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction Eur Heart J 28 2007 766 772
53. T. Saigawa, K. Kato, T. Ozawa, K. Toba, Y. Makiyama, and S. Minagawa Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells Circ J 68 2004 1189 1193
54. M. Gyngysi, I. Lang, M. Dettke, G. Beran, S. Graf, and H. Sochor Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study Nat Clin Pract Cardiovasc Med 6 2009 70 81
55. K. Miyamoto, K. Nishigami, N. Nagaya, K. Akutsu, M. Chiku, and M. Kamei Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans Circulation 114 2006 2679 2684
56. S. Matoba, T. Tatsumi, T. Murohara, T. Imaizumi, Y. Katsuda, and M. Ito Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia Am Heart J 156 2008 1010 1018